Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RPS6KA5 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → RPS6KA5 |
| (<<) CASP6 → RPS6KA5 |
| (<<) CXADR → RPS6KA5 |
| (<<) FOS → RPS6KA5 |
| (<<) FZD7 → RPS6KA5 |
| (<<) GNG11 → RPS6KA5 |
| (<<) IER3 → RPS6KA5 |
| (<<) ITPR3 → RPS6KA5 |
| (<<) KLF4 → RPS6KA5 |
| (<<) NDRG1 → RPS6KA5 |
| (<<) NUPR1 → RPS6KA5 |
| (<<) PPP2R5C → RPS6KA5 |
| (<<) PRKAB1 → RPS6KA5 |
| (<<) SET → RPS6KA5 |
| Downstream (Children) |
|---|
| RPS6KA5 → APH1B (>>) |
| RPS6KA5 → BMP2 (>>) |
| RPS6KA5 → CASP2 (>>) |
| RPS6KA5 → CASP5 (>>) |
| RPS6KA5 → CKB (>>) |
| RPS6KA5 → CLCA4 (>>) |
| RPS6KA5 → DOCK9 (>>) |
| RPS6KA5 → JHDM1D (>>) |
| RPS6KA5 → KRT34 (>>) |
| RPS6KA5 → NFATC3 (>>) |
| RPS6KA5 → PDPK1 (>>) |
| RPS6KA5 → PLOD2 (>>) |
| RPS6KA5 → RBP1 (>>) |
| RPS6KA5 → RCOR1 (>>) |
| RPS6KA5 → ROR1 (>>) |
| RPS6KA5 → THRA (>>) |
